Voyager stockholders elect three Class III directors, approve say-on-pay, ratify auditor

Voyager Therapeutics, Inc.

Michael Higgins, Jude Onyia, and Nancy Vitale elected Class III directors until 2027.
Non-binding advisory vote on executive compensation passed with 35.9M for vs 1.7M against.
Ratification of Ernst & Young as independent auditor for FY2024 with 46.3M for, 72K against.
Broker non-votes of 8.6M on director elections and say-on-pay; none on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.